We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Sensitive Estrogen Detection Method Developed

By LabMedica International staff writers
Posted on 13 Jan 2015
The hormone estrogen plays an important role in the human body and has been linked to everything from tumor growth to neuron loss during Alzheimer's disease, but detecting very small amounts of it in blood and other biological fluids can be difficult, especially in the limited amounts available in laboratory studies.

A new method for detecting trace amounts of estrogen has been developed that uses liquid chromatography-mass spectrometry (LC-MS) and tandem mass spectrometry (LC-MS/MS) which remains the most sensitive and specific technique for both quantitative and qualitative analysis of small molecules in biological samples. More...


Scientists at the University of Texas (Arlington, TX, USA) developed a method for ultra-trace determination of estrogens in human serum using a combination of charged bulk derivatization and weak cation exchange (WCX) RAM-based trap-and-elute LC–MS/MS. The LC system was equipped with four pumps (Pump A/B: LC-30AD, Pump C/D: LC-20AD XR), a SIL-30AC AS, and a CTO-30A column oven containing a 2-position six-port switching valve. The analyses have been performed with a prototype WCX RAM trap column (Shimadzu Corporation; Kyoto, Japan). The LC–MS/MS analysis was performed on a Shimadzu LCMS-8050 triple quadrupole mass spectrometer.

Mass spectrometry and chromatography are ways to separate, identify, and quantify molecules in a complex mixture. The process involving liquid chromatography-electrospray ionization-tandem mass spectrometry relies on a vital step called charge derivatization or using a permanently charged reagent to selectively trap the estrogens and isolate them from the lipids and proteins that could interfere with estrogen detection. The limits of detection (LODs) in the study were found to be 3 pg/mL for estriol, 7 pg/mL for estrone and 17α-estradiol, and 5 pg/mL for 17β-estradiol. The new method can be accomplished in less than 25 minutes, including sample preparation and was a sensitive and efficient method for detecting trace amounts at less than 10 parts per trillion in a 100 mL sample.

Jose A. Barrera, PhD, director of the Shimadzu Institute and a coauthor of the study, said, “This new method pushes the detection limit for estrogens to a level that is applicable to research, human health, medicine, and environmental analysis. Its being instituted as a routine service means that all scientists now have the capability to more closely relate research model findings to human health and physiology.” The study was published on November 27, 2014, in the journal Analytica Chimica Acta.

Related Links:

University of Texas
Shimadzu Corporation 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.